Miller W R, Telford J, Dixon J M, Hawkins R A
Eur J Cancer Clin Oncol. 1985 Apr;21(4):539-42. doi: 10.1016/0277-5379(85)90049-5.
Androgen receptor activity was measured in tumours from 122 patients with breast cancer. Forty-two tumours (34%) possessed androgen receptors at levels varying from 17 to 210 fmol/mg cytosol protein (mean value 68). No relationship was detected between androgen receptors and menopausal status of the patients and whether or not lymph nodes were invaded with tumour at the time of biopsy. There were, however, significant positive correlations between the presence of androgen receptors and that of oestrogen (P less than 0.05) and of progestogen receptors (P less than 0.025). These relationships suggest that androgen receptors may be of value in predicting the hormone responsiveness of breast tumours but definitive proof of this requires clinical follow-up of the patients studied.
对122例乳腺癌患者的肿瘤组织进行了雄激素受体活性检测。42例肿瘤(34%)的雄激素受体水平在17至210 fmol/mg胞浆蛋白之间变化(平均值为68)。未发现雄激素受体与患者的绝经状态以及活检时肿瘤是否侵犯淋巴结之间存在关联。然而,雄激素受体的存在与雌激素受体(P<0.05)和孕激素受体(P<0.025)的存在之间存在显著正相关。这些关系表明,雄激素受体可能在预测乳腺肿瘤的激素反应性方面具有价值,但这需要对所研究的患者进行临床随访才能得到确切证实。